MedTrace Logo

Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance

NCT06219577 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-04-08

Study results available
· View outcomes & findings →

Summary

Single site, prospective, double-masked, randomized-controlled, two-arm study of the dry eye symptoms as well as corneal and conjunctival staining in subjects using 2 different eyedrops. Subjects will be assessed at a screening visit, and 2 follow-up visits. Clinical evaluations will include patient questionnaire, tear-breakup time, and slit lamp exam.

Conditions

  • Dry Eye

Interventions

DRUG

Systane Complete Multi-Dose PF

Eyedrop

DRUG

Walgreen's Lubricant Balance

Eyedrop

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Scripps Poway Eyecare and Optometry

    lead OTHER

Principal Investigators

  • Jay Mashouf, OD · Scripps Poway Eyecare & Optometry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-18
Primary Completion
2024-04-22
Completion
2024-04-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06219577 on ClinicalTrials.gov